VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Ferguson Enterprises Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Ferguson Enterprises Inc.
FERG · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Ferguson Enterprises Inc.'s moat claims, evidence, and risks.
View FERG analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 72 / 100 for Ferguson Enterprises Inc.).
- Segment focus: Ferguson Enterprises Inc. has 2 segments (95.1% in United States); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Ferguson Enterprises Inc. has 4 moat types across 2 domains; Sanofi has 5 across 3.
Primary market context
Ferguson Enterprises Inc.
United States
Value-added distribution of plumbing, HVAC, PVF, waterworks and related products/services
United States
Residential and non-residential professional trade customers (contractors/builders) plus industrial and infrastructure customers
Value-added distributor (B2B)
95.1%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Ferguson Enterprises Inc. strengths
Sanofi strengths
Segment mix
Ferguson Enterprises Inc. segments
Full profile >United States
Competitive
Canada
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.